Treatment of Retinoblastoma in 2015: Agreement and Disagreement

The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurg...

Full description

Saved in:
Bibliographic Details
Published inJAMA ophthalmology Vol. 133; no. 11; p. 1341
Main Authors Abramson, David H, Shields, Carol L, Munier, Francis L, Chantada, Guillermo L
Format Journal Article
LanguageEnglish
Published United States 01.11.2015
Subjects
Online AccessGet more information
ISSN2168-6173
DOI10.1001/jamaophthalmol.2015.3108

Cover

Loading…
Abstract The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival.
AbstractList The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival.
Author Shields, Carol L
Chantada, Guillermo L
Munier, Francis L
Abramson, David H
Author_xml – sequence: 1
  givenname: David H
  surname: Abramson
  fullname: Abramson, David H
  organization: Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill-Cornell Medical Center, New York, New York
– sequence: 2
  givenname: Carol L
  surname: Shields
  fullname: Shields, Carol L
  organization: Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
– sequence: 3
  givenname: Francis L
  surname: Munier
  fullname: Munier, Francis L
  organization: Jules-Gonin Eye Hospital, Faculté de Biologie et Médecine de Lausanne, Lausanne, Switzerland
– sequence: 4
  givenname: Guillermo L
  surname: Chantada
  fullname: Chantada, Guillermo L
  organization: Research Institute, Hospital J.P. Garrahan, Buenos Aires, Argentina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26378747$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tqwzAUREVpadI0v1D0A3bvlWRL7qaE9AmBQknX4dqSGgdLMra76N_3mdkMDIcDc8FOY4qOMY6QIwBeHyhQ6vfTnrqQulwAFrlEMCdsLrA0WYlazthyHA_wHQOgZHHOZqKU2mil5-x2OziagosTT56_uqmNqe5onFIg3kb-Y7zhq_fBuV-IouV37UjH4ZKdeepGt_zvBXt7uN-un7LNy-PzerXJSJZ6yjQotABaWU_COiW9MOhsXRa1AtVUCgx6rGzRNAhOVUXjPAEagTV5r1As2NWft_-og7O7fmgDDZ-74xPxBV4wTqA
CitedBy_id crossref_primary_10_1016_j_oftal_2017_10_010
crossref_primary_10_1177_1591019917738962
crossref_primary_10_1200_JCO_19_01096
crossref_primary_10_3389_fonc_2022_848877
crossref_primary_10_1167_iovs_64_15_31
crossref_primary_10_3390_antibiotics11050561
crossref_primary_10_1002_iub_1886
crossref_primary_10_1002_kjm2_12523
crossref_primary_10_1515_med_2021_0343
crossref_primary_10_1007_s10792_021_01759_4
crossref_primary_10_1136_bjophthalmol_2017_310294
crossref_primary_10_1016_j_jtos_2020_11_006
crossref_primary_10_1159_000515142
crossref_primary_10_1038_s43018_020_00119_y
crossref_primary_10_3892_ijmm_2020_4547
crossref_primary_10_1126_scitranslmed_aat9321
crossref_primary_10_1002_pbc_28882
crossref_primary_10_1007_s13258_021_01043_w
crossref_primary_10_1155_2022_2470890
crossref_primary_10_1371_journal_pone_0160094
crossref_primary_10_3389_fimmu_2023_1097456
crossref_primary_10_4103_tjo_TJO_D_24_00107
crossref_primary_10_1136_bjophthalmol_2016_309298
crossref_primary_10_4103_joco_joco_323_21
crossref_primary_10_3892_mmr_2017_7396
crossref_primary_10_1016_j_jfo_2022_06_018
crossref_primary_10_1016_j_preteyeres_2019_05_005
crossref_primary_10_3389_fmed_2022_855661
crossref_primary_10_3390_jcm11216254
crossref_primary_10_1016_j_jaapos_2016_07_230
crossref_primary_10_18632_aging_103075
crossref_primary_10_3390_cancers13092216
crossref_primary_10_1007_s12033_021_00443_3
crossref_primary_10_1016_j_jconrel_2017_08_018
crossref_primary_10_1186_s40942_017_0093_8
crossref_primary_10_2147_OPTH_S398488
crossref_primary_10_1016_j_addr_2023_115006
crossref_primary_10_3390_cancers12082304
crossref_primary_10_1007_s12031_017_1017_7
crossref_primary_10_1097_IAE_0000000000001962
crossref_primary_10_1002_jcp_27812
crossref_primary_10_1038_s41433_022_01980_0
crossref_primary_10_1111_1440_1681_13263
crossref_primary_10_1136_neurintsurg_2019_015597
crossref_primary_10_1016_j_jaapos_2020_12_006
crossref_primary_10_1016_j_preteyeres_2020_100848
crossref_primary_10_1039_D2BM01005D
crossref_primary_10_3389_fmed_2021_675703
crossref_primary_10_3390_bioengineering9110671
crossref_primary_10_1016_j_oftal_2018_05_003
crossref_primary_10_1038_srep35264
crossref_primary_10_1136_bjophthalmol_2016_309710
crossref_primary_10_1001_jamaophthalmol_2024_4859
crossref_primary_10_4103_2347_5625_207737
crossref_primary_10_1167_tvst_10_11_10
crossref_primary_10_1001_jama_2024_21396
crossref_primary_10_1371_journal_pone_0151343
crossref_primary_10_1007_s40135_017_0138_z
crossref_primary_10_1016_j_oftale_2018_01_002
crossref_primary_10_1159_000491432
crossref_primary_10_3928_23258160_20191211_06
crossref_primary_10_1016_j_canlet_2016_06_012
crossref_primary_10_4103_ijo_IJO_642_19
crossref_primary_10_1038_s41388_017_0050_x
crossref_primary_10_4103_ijo_IJO_576_20
crossref_primary_10_3389_fmed_2022_1015301
crossref_primary_10_1016_j_xops_2021_100042
crossref_primary_10_3390_cancers13081862
crossref_primary_10_1038_s41388_020_1372_7
crossref_primary_10_3389_fonc_2024_1372548
crossref_primary_10_1016_j_clp_2020_12_001
crossref_primary_10_1016_j_oret_2024_11_005
crossref_primary_10_1177_11206721231155671
crossref_primary_10_1002_14651858_CD012366_pub2
crossref_primary_10_1007_s00112_017_0364_3
crossref_primary_10_1097_IAE_0000000000002315
crossref_primary_10_4143_crt_2021_1537
crossref_primary_10_1002_pbc_26270
crossref_primary_10_1097_APO_0000000000000360
crossref_primary_10_1038_s41433_021_01845_y
crossref_primary_10_1167_iovs_63_9_20
crossref_primary_10_1038_s41420_021_00622_w
crossref_primary_10_1186_s12885_020_07314_1
crossref_primary_10_1080_13816810_2017_1393826
crossref_primary_10_1007_s00717_021_00514_5
crossref_primary_10_1177_2474126416677898
crossref_primary_10_1016_j_jbc_2025_108199
crossref_primary_10_1158_1078_0432_CCR_24_0221
crossref_primary_10_1371_journal_pone_0197052
crossref_primary_10_1177_107327481602300203
crossref_primary_10_1080_01676830_2017_1423358
crossref_primary_10_3390_cancers13081876
crossref_primary_10_1002_pbc_28963
crossref_primary_10_1007_s10384_024_01067_1
crossref_primary_10_1007_s00717_023_00550_3
crossref_primary_10_1016_j_jaapos_2023_08_013
crossref_primary_10_1016_j_ophtha_2017_01_048
crossref_primary_10_1007_s12272_018_1094_3
crossref_primary_10_1111_aos_14759
crossref_primary_10_1016_j_ijrobp_2018_12_004
crossref_primary_10_1016_j_ophtha_2020_09_021
crossref_primary_10_1016_j_jaapos_2022_11_014
crossref_primary_10_1016_j_nic_2023_05_011
crossref_primary_10_1016_j_oret_2017_03_013
crossref_primary_10_1097_MD_0000000000012676
crossref_primary_10_1097_IIO_0000000000000266
crossref_primary_10_1002_pbc_31044
crossref_primary_10_1016_j_heliyon_2024_e27653
crossref_primary_10_3390_ijms20051077
crossref_primary_10_1136_neurintsurg_2016_012758
crossref_primary_10_1002_cnr2_1702
crossref_primary_10_1002_cnr2_1949
crossref_primary_10_1097_MPH_0000000000000968
crossref_primary_10_2147_CMAR_S268380
crossref_primary_10_3174_ajnr_A6590
crossref_primary_10_1016_j_oftale_2018_05_014
crossref_primary_10_1016_j_bbrc_2020_03_083
crossref_primary_10_12677_ACM_2024_141266
crossref_primary_10_1136_bjophthalmol_2019_315209
crossref_primary_10_1097_IAE_0000000000001382
crossref_primary_10_1007_s40135_017_0123_6
crossref_primary_10_1097_IIO_0000000000000151
crossref_primary_10_1093_jnci_djy227
crossref_primary_10_1016_j_biopha_2021_111371
crossref_primary_10_1097_APO_0000000000000172
crossref_primary_10_1016_j_bbrc_2021_07_099
crossref_primary_10_1055_a_2237_2943
crossref_primary_10_1186_s40942_018_0124_0
crossref_primary_10_1038_s41598_019_56623_4
crossref_primary_10_1111_aos_14222
crossref_primary_10_1016_j_ijpharm_2020_119824
crossref_primary_10_1080_10717544_2020_1730522
crossref_primary_10_1002_pbc_27959
crossref_primary_10_22608_APO_201778
crossref_primary_10_1371_journal_pone_0197081
crossref_primary_10_1002_cam4_5406
crossref_primary_10_21682_2311_1267_2021_8_1_50_56
crossref_primary_10_1167_iovs_18_25346
crossref_primary_10_4103_JNSM_JNSM_58_20
crossref_primary_10_1002_pbc_26908
crossref_primary_10_3390_children9121939
crossref_primary_10_1542_neo_22_7_e423
crossref_primary_10_1007_s10792_020_01472_8
crossref_primary_10_1080_13816810_2018_1443343
crossref_primary_10_1093_neuros_nyaa142
crossref_primary_10_3389_fgene_2022_864473
crossref_primary_10_3928_23258160_20180129_04
crossref_primary_10_2147_OTT_S370878
crossref_primary_10_1136_bjophthalmol_2017_310624
crossref_primary_10_1002_pbc_26193
crossref_primary_10_3928_01913913_20170201_03
crossref_primary_10_1016_j_colsurfb_2016_07_001
crossref_primary_10_1136_bjophthalmol_2020_317934
crossref_primary_10_14348_molcells_2022_2014
crossref_primary_10_1080_13816810_2016_1244695
crossref_primary_10_1167_iovs_61_6_41
crossref_primary_10_3238_arztebl_2018_0106
crossref_primary_10_1186_s12886_021_02170_4
crossref_primary_10_18632_oncotarget_14487
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1001/jamaophthalmol.2015.3108
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6173
ExternalDocumentID 26378747
Genre Multicenter Study
Journal Article
Review
GroupedDBID 0R~
4.4
53G
AAWTL
ABJNI
ACGFS
ACNCT
ACPRK
ADBBV
AENEX
AFOSN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BCGUY
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EJD
EMOBN
EX3
H13
NPM
OB3
OBH
OGROG
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WOW
ID FETCH-LOGICAL-a367t-7041d0074dfa2de43f281edb65b404c94081f19d5cc10e495cefa01821baff412
IngestDate Thu Jan 02 22:19:58 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a367t-7041d0074dfa2de43f281edb65b404c94081f19d5cc10e495cefa01821baff412
PMID 26378747
ParticipantIDs pubmed_primary_26378747
PublicationCentury 2000
PublicationDate 2015-Nov
PublicationDateYYYYMMDD 2015-11-01
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-Nov
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAMA ophthalmology
PublicationTitleAlternate JAMA Ophthalmol
PublicationYear 2015
SSID ssj0000800435
Score 2.5547512
SecondaryResourceType review_article
Snippet The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this...
SourceID pubmed
SourceType Index Database
StartPage 1341
SubjectTerms Antineoplastic Agents - administration & dosage
Brachytherapy
Cryotherapy
Eye Enucleation
Humans
Infusions, Intra-Arterial
Intravitreal Injections
Laser Coagulation
Ophthalmic Artery
Retinal Neoplasms - pathology
Retinal Neoplasms - therapy
Retinoblastoma - pathology
Retinoblastoma - therapy
Title Treatment of Retinoblastoma in 2015: Agreement and Disagreement
URI https://www.ncbi.nlm.nih.gov/pubmed/26378747
Volume 133
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6rgngR32_JwdtSadqk23oR8YmopxX2tiRNgivbdsF68dc7SdN2V1ZRL2XJsH3N18k3wzwQOglUkDLYeD2meM-jsaBeInrUM-hKhZJmkzHZFk_R3TO9H7BBp_MxXV1SitP0Y25dyX-0CmugV1Ml-wfNNieFBfgN-oUjaBiOv9NxkyVuW4qUo7wQwIbLIuMmjgG7LrOBP_CpVZNMfjV64_XCDDUF89stJi_lCx9nM8H2C_CoM1eZZXPg24oGM0p7LN-a1JHuQ6vBfFTBwc3uaEWmoqHk0tLW23dbjJgVTuwCEIS5Sjy7f1hDFZAoNqWG4YxVrfpb1PAhU0bS9JCba73bqQHt05rsO3YKJDSe_gu8vElmtRpEIdicqmvnz9IvfbVr0QJaAA_DjEx1cZ5Xx6OBSLrUr7pN1by7Mt2k3Zm-eCaWofTX0KpzLfBFhZN11FH5Blp-dMkTm-i8gQsuNJ6FCx7l2FzsDDdgwQAWPA2WLfR8c92_vPPc_AyPh1Gv9Ho-JdJwRKl5IBUNdRATJUXEBPVpmlCgg5okkqUp8RV4yqnS3AeHkwiuNSXBNlrMi1ztIhzQKNVJ7EsmKZWhFJQQlfgiiSjxQxHuoZ3q0YeTqknKsH4p-99KDtBKC6dDtKThq1RHQPFKcWy18Qnu8E5x
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+Retinoblastoma+in+2015%3A+Agreement+and+Disagreement&rft.jtitle=JAMA+ophthalmology&rft.au=Abramson%2C+David+H&rft.au=Shields%2C+Carol+L&rft.au=Munier%2C+Francis+L&rft.au=Chantada%2C+Guillermo+L&rft.date=2015-11-01&rft.eissn=2168-6173&rft.volume=133&rft.issue=11&rft.spage=1341&rft_id=info:doi/10.1001%2Fjamaophthalmol.2015.3108&rft_id=info%3Apmid%2F26378747&rft_id=info%3Apmid%2F26378747&rft.externalDocID=26378747